Rebus Holdings Inc (RBSH)

[AAAAMHIM]

NSPX 003??? LMFAAAAAOOOO. Weak hands out THINNER to .02s now. THE FACT REMAINS that only 150 million authorized shares. FDA CLEARED BRAIN CANCER DRUG with PROVEN results. SHARES GETTING SOAKED UP.

HOW LONG HAS IT BEEN SOAKED UP HERE AT 003s no matter how much pressure applied BIDS keep coming in. BOTTOM

UNDERSTAND THE IMPORTANCE OF SHARE STRUCTURE. PERIOD

WHAT DO DOCTORS SAY ABOUT OUR DRUG? 

;

This is cancer we are talking about. Cures dont happen overnight but NAME A STOCK THAT ACTUALLY HAS A DRUG THAT WORKS for brain cancer trading less than $50 per share. 

KEEP SLEEPING. WE ARE LOCKING THIS FLOAT. PERIOD. 125 million O/S (after today probably more like 145) 150 million A/S???!!! .003?? WHAT??

$GNSZ's Ph 2 mipsagargin data for #GBM showed clinical benefit in a subset of #glioblastoma patients. https://t.co/9bzvYKM0HA #SNO15 ;

Santosh Kesari, MD, PhD 

https://www.curetoday.com/articles/above-and-beyond-a-celebration-of-heroes-of-glioblastoma ;

https://xconomy.com/texas/2016/02/03/pursuing-partner-genspera-tests-toxin-based-drug-in-brain-cancer/ ;

https://www.pacificneuroscienceinstitute.org/people/kesari/https://abc7.com/health/doctor-improves-cancer-teens-health-with-game-changing-approach/1175310/ ;

$GNSZ combines powerful insights and rigorous scientific methods to create new treatment options for patients. https://t.co/oAwCWxky1HLearn more about mipsagargin's unique mechanism of action that helps destroy #tumors. https://t.co/NbEj6pHSdp $GNSZ #cancer ;

GNSZ's patented technology platform has the potential to target different #cancers. Click to learn more: https://t.co/aIiLNdfgm3https://www.google.com/search?source=hp&ei=E-D7W4jHOsS-ggeM_pL4Cw&q=thapsigargin&oq=thapsi&gs_l=mobile-gws-wiz-hp.1.0.0l2j46i10j0j46i10.2095.4643..7756...1.0..0.346.1347.0j2j3j1......0....1.......5..46j35i39j46i39j0i131j46i131.fN_PcqrV8QM ;


https://www.facebook.com/GenSpera/videos/849502461751662/ ;

NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX